Tesamorelin is a synthetic peptide that stimulates the release of endogenous growth hormone (GH) by mimicking Growth Hormone–Releasing Hormone (GHRH). Originally FDA-approved for reducing abdominal fat in HIV-associated lipodystrophy, Tesamorelin has since gained recognition for its ability to significantly reduce visceral fat, improve body composition, and support metabolic health in aging adults and those with stubborn abdominal fat.
Tesamorelin works by promoting the natural release of growth hormone, enhancing lipolysis (fat breakdown), increasing muscle tone, improving recovery, and supporting cognitive and cardiovascular function—all while preserving the body’s natural feedback loop to prevent overstimulation.
Precision Health provides compounded Tesamorelin therapy via subcutaneous injection, guided by licensed providers through a fully virtual care model. Our clinical team monitors your progress with optional lab work and provides dosing adjustments to optimize outcomes—all delivered discreetly to your door.
Key Benefits:
Common Dosage: 1–2 mg daily, subcutaneously (usually at bedtime)
Form: Compounded peptide injection
Route: Subcutaneous (SQ)
Prescription Required: Yes
Monitoring: Optional labs and virtual check-ins for safety and efficacy